Private company
Vivo Opportunity, LLC
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
Vivo Opportunity, LLC sits at the top of its group. 6 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Vivo Opportunity, LLC DE
- Avadel Pharmaceuticals Stake · Lyon
- Catabasis Pharmaceuticals Stake · Cambridge
- Geron Corporation Stake · Menlo Park, California, United States
- Verastem Oncology Stake · Needham
- Viridian Therapeutics, Inc.\DE Stake · Waltham, Massachusetts
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.
Stakes it holds
Vivo Opportunity, LLC has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).
- Catabasis PharmaceuticalsSC 13G/A Sep 8, 2022 to Feb 13, 20242
- Verastem OncologySC 13G/A Feb 13, 20243
- Avadel PharmaceuticalsSC 13G/A Feb 11, 2022 to Feb 14, 20234
- Geron CorporationSC 13G/A Apr 8, 2022 to Feb 14, 20235
- Viridian Therapeutics, Inc.\DESC 13G/A Feb 14, 20236
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6